Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011
NEW YORK, July 7, 2011 /PRNewswire/ --
Reportlinker.com announces that a new market research report is available in its catalogue:
Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011
http://www.reportlinker.com/p0567402/Benign-Prostatic-Hyperplasia-Global-Clinical-Trials-Review-Q2-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development
Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011
Summary
GlobalData's clinical trial report, "Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011" provides data on the Benign Prostatic Hyperplasia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Benign Prostatic Hyperplasia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Benign Prostatic Hyperplasia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Benign Prostatic Hyperplasia 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Benign Prostatic Hyperplasia 20
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Benign Prostatic Hyperplasia Therapeutics Clinical Trials 26
Prominent Drug Comparison 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
GlaxoSmithKline plc 29
Clinical Trial Overview of GlaxoSmithKline plc 29
Eli Lilly and Company 31
Clinical Trial Overview of Eli Lilly and Company 31
Sanofi 32
Clinical Trial Overview of Sanofi 32
Astellas Pharma Inc. 33
Clinical Trial Overview of Astellas Pharma Inc. 33
Health Ever Bio-Tech Co., Ltd. 34
Clinical Trial Overview of Health Ever Bio-Tech Co., Ltd. 34
Watson Pharmaceuticals, Inc. 35
Clinical Trial Overview of Watson Pharmaceuticals, Inc. 35
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
Nymox Pharmaceutical Corporation 37
Clinical Trial Overview of Nymox Pharmaceutical Corporation 37
AEterna Zentaris Inc. 38
Clinical Trial Overview of AEterna Zentaris Inc. 38
Allergan, Inc. 39
Clinical Trial Overview of Allergan, Inc. 39
QLT Inc. 40
Clinical Trial Overview of QLT Inc. 40
American Medical Systems Holdings, Inc. 41
Clinical Trial Overview of American Medical Systems Holdings, Inc. 41
Light Sciences Oncology, Inc. 42
Clinical Trial Overview of Light Sciences Oncology, Inc. 42
Bayer AG 43
Clinical Trial Overview of Bayer AG 43
Threshold Pharmaceuticals, Inc. 44
Clinical Trial Overview of Threshold Pharmaceuticals, Inc. 44
Spectrum Pharmaceuticals, Inc. 45
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 45
Actavis, Inc. 46
Clinical Trial Overview of Actavis, Inc. 46
HANDOK Pharmaceuticals Co., Ltd. 47
Clinical Trial Overview of HANDOK Pharmaceuticals Co., Ltd. 47
Ferring Pharmaceuticals 48
Clinical Trial Overview of Ferring Pharmaceuticals 48
Sun Pharmaceutical Industries Limited 49
Clinical Trial Overview of Sun Pharmaceutical Industries Limited 49
Clinical Trial Overview of Top Universities / Institutes / Hospitals 50
Samsung Medical Center 50
Clinical Trial Overview of Samsung Medical Center 50
The National Institute of Diabetes and Digestive and Kidney Diseases 51
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 51
Hospital Authority 52
Clinical Trial Overview of Hospital Authority 52
Seoul National University Hospital 53
Clinical Trial Overview of Seoul National University Hospital 53
Assistance Publique - Hopitaux de Paris 54
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 54
The International Kidney Stone Institute 55
Clinical Trial Overview of The International Kidney Stone Institute 55
The University of Tokyo Hospital 56
Clinical Trial Overview of The University of Tokyo Hospital 56
Erasmus MC 57
Clinical Trial Overview of Erasmus MC 57
University of California, San Francisco 58
Clinical Trial Overview of University of California, San Francisco 58
University of California, Irvine 59
Clinical Trial Overview of University of California, Irvine 59
Northwestern University 60
Clinical Trial Overview of Northwestern University 60
University of Alberta 61
Clinical Trial Overview of University of Alberta 61
Hospices Civils de Lyon 62
Clinical Trial Overview of Hospices Civils de Lyon 62
University of Washington 63
Clinical Trial Overview of University of Washington 63
University of Missouri 64
Clinical Trial Overview of University of Missouri 64
Southwest Hospital, China 65
Clinical Trial Overview of Southwest Hospital, China 65
Weill Cornell Medical College 66
Clinical Trial Overview of Weill Cornell Medical College 66
Chinese University of Hong Kong 67
Clinical Trial Overview of Chinese University of Hong Kong 67
Queen's University 68
Clinical Trial Overview of Queen's University 68
Lawson Health Research Institute 69
Clinical Trial Overview of Lawson Health Research Institute 69
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 72
About GlobalData 72
Contact Us 73
Disclaimer 73
Source 73
List of Tables
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Zone, 2011* 8
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011* 11
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 12
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, North America, Top Countries, 2011* 13
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011* 14
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 15
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, BRIC Countries, 2011* 16
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Phase, 2011* 17
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 18
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Benign Prostatic Hyperplasia Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 20
Benign Prostatic Hyperplasia Therapeutics Market, Global, Terminated Clinical Trials, 2011* 21
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 25
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 27
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 28
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 29
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011* 31
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011* 32
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2011* 33
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Ever Bio-Tech Co., Ltd., 2011* 34
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Watson Pharmaceuticals, Inc., 2011* 35
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 36
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nymox Pharmaceutical Corporation, 2011* 37
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2011* 38
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2011* 39
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2011* 40
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by American Medical Systems Holdings, Inc., 2011* 41
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2011* 42
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2011* 43
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Threshold Pharmaceuticals, Inc., 2011* 44
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2011* 45
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis, Inc., 2011* 46
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by HANDOK Pharmaceuticals Co., Ltd., 2011* 47
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, 2011* 48
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2011* 49
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2011* 50
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011* 51
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2011* 52
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2011* 53
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2011* 54
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The International Kidney Stone Institute, 2011* 55
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2011* 56
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2011* 57
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011* 58
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2011* 59
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2011* 60
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2011* 61
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2011* 62
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011* 63
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2011* 64
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Hospital, China, 2011* 65
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2011* 66
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2011* 67
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2011* 68
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2011* 69
List of Figures
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 8
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 11
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 12
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 13
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011* 14
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 15
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, BRIC Countries (%), 2011* 16
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 17
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 18
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 24
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 26
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 28
GlobalData Methodology 72
Companies Mentioned
To order this report:
Drug Discovery and Development Industry: Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011
Drug Discovery and Development Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article